Skip to main content
12 April 2021
Last updated:
Sunday 11 April 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
  • Research Directory
  • Contact Us

News - Appointments

Yilmaz Mahshid becomes CEO of Medivir

Monday 7 September 2020
Company
Medivir AB
Appointee Name
Yilmaz 
Mahshid

Yilmaz Mahshid is to join the Swedish biotech company Medivir AB as chief executive officer, replacing Uli Hacksell, who will stay on the board of directors.

Country

Sweden

  • Read more about Yilmaz Mahshid becomes CEO of Medivir

Sobi appoints Ravi Rao as new head of research and development

Sunday 6 September 2020
Company
Swedish Orphan Biovitrum AB
Appointee Name
Ravi 
Rao

Ravi Rao has joined Sobi (Swedish Orphan Biovitrum AB) as its new head of research and development, replacing Milan Zdravkovic who is leaving the company.

Country

Sweden

  • Read more about Sobi appoints Ravi Rao as new head of research and development

Sven Rohmann appointed CEO of Immunicum

Friday 28 August 2020
Company
Immunicum AB
Appointee Name
Sven 
Rohmann

Sven Rohmann, a medical doctor and biotech executive, has been appointed chief executive of Immunicum AB to lead clinical development of the Swedish company’s cell-based therapy for cancer.

Country

Sweden

  • Read more about Sven Rohmann appointed CEO of Immunicum

Neil Bell joins Avacta as chief development officer

Sunday 16 August 2020
Company
Avacta Life Sciences Ltd
Appointee Name
Neil 
Bell

Neil Bell, an expert in clinical development, has joined Avacta Life Sciences Ltd as chief development officer to manage human studies of the company’s lead drug, a pro-doxorubicin compound.

Country

United Kingdom

  • Read more about Neil Bell joins Avacta as chief development officer

Erich Schlick becomes chair of NBE-Therapeutics

Sunday 16 August 2020
Company
NBE-Therapeutics GmbH
Appointee Name
Erich 
Schlick

Erich Schlick, a venture capitalist and industrialist, has been appointed chair of the board of directors of Switzerland-based NBE-Therapeutics GmbH which is developing antibody-drug conjugates. He is currently a general partner and managing director at Wellington Partners in Munich.

Country

Switzerland

  • Read more about Erich Schlick becomes chair of NBE-Therapeutics

Nordic Nanovector appoints new CMO

Sunday 16 August 2020
Company
Nordic Nanovector ASA
Appointee Name
Christine 
Wilkinson Blanc

Nordic Nanovector ASA has appointed Christine Wilkinson Blanc as chief medical officer to help it advance its portfolio of targeted cancer therapies.

Country

Norway

  • Read more about Nordic Nanovector appoints new CMO

Peter Selin becomes CBO at Oasmia Pharmaceutical

Sunday 16 August 2020
Company
Oasmia Pharmaceutical AB
Appointee Name
Peter 
Selin

Peter Selin, an experienced business development executive, has been appointed chief business officer at Oasmia Pharmaceutical AB, a Swedish specialty pharma company.

Country

Sweden

  • Read more about Peter Selin becomes CBO at Oasmia Pharmaceutical

Thomas Burt joins Redx Pharma board

Sunday 16 August 2020
Company
Redx Pharma Plc
Appointee Name
Thomas 
Burt

Thomas Burt, a venture capitalist, has become a non-executive director at Redx Pharma Plc, representing the Sofinnova Crossover Fund, a recent investor. Mr Burt has been a partner in the fund since its inception in 2017.

Country

United Kingdom

  • Read more about Thomas Burt joins Redx Pharma board

Valneva appoints chief medical officer

Sunday 16 August 2020
Company
Valneva SE
Appointee Name
Juan Carlos 
Jaramillo

The France-based vaccine company Valneva SE has appointed Juan Carlos Jaramillo as chief medical officer, effective 1 October, to lead the company’s portfolio of preventive treatments against Lyme disease, chikungunya and SARS-COV-2.

Country

France

  • Read more about Valneva appoints chief medical officer

Valo Therapeutics appoints Paul Higham as CEO

Sunday 16 August 2020
Company
Valo Therapeutics Ltd
Appointee Name
Paul 
Higham

Paul Higham, an experienced manager, has joined Valo Therapeutics Ltd as chief executive to lead the company through a new financing round and help take its first oncolytic virus compound into the clinic.

Country

United Kingdom

  • Read more about Valo Therapeutics appoints Paul Higham as CEO

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page next ›
  • Last page last »

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

René Hoet becomes CSO at Montis Biosciences
Wednesday March 31 2021
Pan Cancer T makes board appointments
Wednesday March 31 2021
Björn Englund appointed CEO at Opterion
Wednesday March 31 2021
Sven Zimmermann joins Inotrem
Wednesday March 31 2021
New director at Mission Therapeutics
Wednesday March 31 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.